Fortress Biotech FBIOP
NASDAQ FBIOP
$18.35 +0.08 (+0.43%)
As of: Aug 21, 2026 · 2:47 PM EDT

Fortress Biotech, Inc. (FBIOP) Operating Margin (2015 - 2026)

Fortress Biotech (FBIOP) posted quarterly Operating Margin of 34.07% for Q4 2025, up 12314.0% year-over-year from N/an in Q4 2024, and up 11.8% quarter-over-quarter from 38.63% in Q3 2025.

Fortress Biotech, Inc. (FBIOP) Operating Margin (2015 - 2026) Analysis & Trends

Fortress Biotech's Operating Margin history runs 11 years deep, the most recent figure standing at 34.07% for Q4 2025.

  • In Q4 2025, Operating Margin rose 12314.0% year-over-year to 34.07%; the TTM figure through Dec 2025 stood at 117.64% (up 7344.0% YoY), while the FY2025 annual figure was 114.67%, up 7671.0% from the prior year.
  • Operating Margin for Q4 2025 stood at 34.07%, up from 38.63% in the prior quarter.
  • The five-year high for Operating Margin was 95.09% in Q4 2022, with the low at 27649.68% in Q2 2021.
  • The 5-year median for Operating Margin is 248.79% (2025), against an average of 4544.47%.
  • The sharpest annual moves came in 2021 and 2022: Operating Margin slumped 2738114 bps in 2021, then surged 2737040 bps in 2022.
  • Fortress Biotech's Operating Margin stood at 106.01% in 2021, then surged by 190 bps to 95.09% in 2022, then tumbled by 235 bps to 128.56% in 2023, then slipped by 22 bps to 157.21% in 2024, then soared by 78 bps to 34.07% in 2025.
  • Business Quant data shows FBIOP's Operating Margin at 34.07% in Q4 2025, 38.63% in Q3 2025, and 243.01% in Q2 2025.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2026 -53.46%
Dec 31, 2025 -34.07%
Sep 30, 2025 -38.63%
Jun 30, 2025 -243.01%
Mar 31, 2025 -169.85%
Dec 31, 2024 -157.21%
Sep 30, 2024 -151.04%
Jun 30, 2024 -186.55%
Mar 31, 2024 -280.63%
Dec 31, 2023 -128.56%
Sep 30, 2023 -7,559.34%
Jun 30, 2023 -27,379.78%
Mar 31, 2023 -483.90%
Dec 31, 2022 95.09%
Sep 30, 2022 -13,937.91%
Jun 30, 2022 -279.28%
Mar 31, 2022 -8,192.37%
Dec 31, 2021 -106.01%
Sep 30, 2021 -254.58%
Jun 30, 2021 -27,649.68%